Paul W. Abramowitz, PharmD, ScD, CEO of American Society of Health System Pharmacists (ASHP) visited the White House along with national leaders from more than 150 major food companies, retailers, and human and animal health stakeholders. He took part in the White House Forum on Antibiotic Stewardship, announcing commitment to make changes over the course of the next five years to slow down the emergence of antibiotic resistant bacteria, find resistant strains, prevent the spread of resistant infections, and continue to preserve the efficacy of antibiotics currently available today. [click to continue…]
According to a recently published report, delaying treatment intensification and follow-up care in patients with high blood pressure can prove fatal.
Researchers at Brigham and Women’s Hospital and of the Beth Israel Deaconess Medical Center in Boston reported in BMJ in February that three factors increase the risk of acute cardiovascular events or death in patients with hypertension. These three factors are: patients whose systolic blood pressure or SPB is greater than 150 mm Hg, delay of treatment intensification by more than 1.4 months, and delay in subsequent follow-up by more than 2.7 months. [click to continue…]
A study recently published in The BMJ has determined that acetaminophen does not do much to provide relief from osteoarthritis pain and low back pain. Some clinical guidelines have recommended using acetaminophen as a first-line therapy. [click to continue…]
Herbal medicine is rising in popularity for its “all natural” label. While many herbal medications do work to treat a number of conditions, it’s important to realize that “all natural” doesn’t always translate to safe – and this is particularly the case for people who are taking prescription drugs, as well. Many herbal preparations interact with prescription medications, so it’s important to educate patients about the possibility of interactions, and always ask about any herbal medications they may be taking alongside the prescriptions they pick up in your pharmacy. [click to continue…]
As part of an effort to reduce 30-day readmission rates, some hospitals are working with local skilled nursing facilities (SNFs). Several programs like this are operating throughout the country.
The Enhanced Care Program or ECP, at Cedars-Sinai Medical Center in Los Angeles began in 2011, later adding a pharmacist to the team. This service is now available for patients who are discharged seven SNFs in the area.
The program works by allowing the ECP nurses to coordinate care between the inpatient and SNF settings, working with doctors in both places to follow up on any unresolved patient care issues. Nurses meet with their patients in the hospital, assess them again within 24 hours after being admitted to the nursing facility, and then visit them at the facility at least once a week. [click to continue…]
On April 29, the FDA approved the biologics license for a new product, Ixinity, a recombinant coagulation factor IX drug, by Cangene Corporation. A spokesperson for the parent company Emergent BioSolutions, Inc. said the product should be available within 60 days. As such, it should be released by the end of the month. [click to continue…]